We are live on ! Find out more
PHGE icon

BiomX
PHGE

10 hedge funds and large institutions have $4.51M invested in BiomX in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0.01% less ownership

Funds ownership: 0.12% → 0.11% (-0.01%)

17% less funds holding

Funds holding: 12 → 10 (-2)

65% less capital invested

Capital invested by funds: $12.8M → $4.51M (-$8.26M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
2
Closed
2
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
-$17K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$19.7K
2
UBS Group
UBS Group
Switzerland
+$9.86K
3
RA
Royce & Associates
New York
+$8.62K

Top Sellers

Rank Fund Capital Flow
1
KC
Kepos Capital
New York
-$870K
2
Millennium Management
Millennium Management
New York
-$19.9K
3
Jane Street
Jane Street
New York
-$2.67K
4
JP Morgan Chase
JP Morgan Chase
New York
-$1K

PHGE Hedge Fund Activity: Q2 2022 in Review

10 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q2 2022, worth a combined $4.51M — down 65% from $12.8M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PHGE and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was Renaissance Technologies, adding an estimated $19.7K. The largest seller was Kepos Capital, exiting entirely with an estimated $870K sold.

  • 10 institutional investors held BiomX (PHGE) as of Q2 2022, down from 12 in Q1 2022.
  • Funds reported $4.51M of BiomX stock for Q2 2022, down 65% quarter-over-quarter.
  • 0 funds opened new BiomX positions in Q2 2022 and 2 closed out, a net change of -2 holders.
  • The largest BiomX buyer in Q2 2022 was Renaissance Technologies, an estimated $19.7K added.
  • The largest BiomX seller in Q2 2022 was Kepos Capital, an estimated $870K sold.

Based on aggregated 13F filings for Q2 2022.